Statins are associated with decreased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: Propensity score-adjusted analysis

Vasa - Journal of Vascular Diseases

Volumn 37, Issue 3, 2008, Pages 241-249

  Diehm, Nicolas ^a   Becker, G ^b   Katzen, B ^c   Benenati, J ^c   Kovacs, M ^c   Dick, F ^d  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ARIZONA   (United States)

^c BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Endovascular repair; Inflammation; Major adverse cardiovascular event

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTIINFLAMMATORY AGENT;

ABDOMINAL AORTA ANEURYSM; AGED; AORTA SURGERY; ARTICLE; CONTROLLED STUDY; DESCENDING AORTA SURGERY; DRUG USE; ELECTIVE SURGERY; ENDOVASCULAR SURGERY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PREDICTION; SURVIVAL RATE; THORACIC AORTA ANEURYSM; THORACIC AORTA SURGERY; ANEMIA; BLOOD VESSEL TRANSPLANTATION; COMPARATIVE STUDY; DATA BASE; KAPLAN MEIER METHOD; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANEMIA; ANTI-INFLAMMATORY AGENTS; AORTIC ANEURYSM, ABDOMINAL; AORTIC ANEURYSM, THORACIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; DATABASES AS TOPIC; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 63049113006     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.37.3.241     Document Type: Article

References (36)

1. Absi TS, Sundt TM, 3rd, Tung WS, Moon M, Lee JK, Damiano RR, Jr., Thompson RW. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 2003; 126: 344-57.
2. Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Sicks JD, Fought AJ, O'Fallon WM, Wiebers DO, Tajik AJ. Is aortic dilatation an atherosclerosis-related process? Clinical, laboratory, and transesophageal echocardiographic correlates of thoracic aortic dimensions in the population with implications for thoracic aortic aneurysm formation. J Am Coll Cardiol 2003; 42: 1076-83.
3. Alcorn HG, Wolfson SK, Jr., Sutton-Tyrrell K, Kuller LH, O'Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996; 16: 963-70.
4. Bonser RS, Pagano D, Lewis ME, Rooney SJ, Guest P, Davies P, Shimada I. Clinical and pathoanatomical factors affecting expansion of thoracic aortic aneurysms. Heart 2000; 84: 277-83.
5. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004; 110: 16-21.
6. Chaikof EL, Blankensteijn JD, Harris PL, White GH, Zarins CK, Bernhard VM, Matsumura JS, May J, Veith FJ, Fillinger MF, Rutherford RB, Kent KC. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg 2002; 35: 1048-60.
7. Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 1994; 331: 1729-34.
8. Diehm N, Benenati JF, Becker GJ, Quesada R, Tsoukas AI, Katzen BT, Kovacs M. Anemia is associated with abdominal aortic aneurysm (AAA) size and decreased long-term survival after endovascular AAA repair. J Vasc Surg 2007; 46: 676-81.
9. Diehm N, Shang A, Silvestro A, Do DD, Dick F, Schmidli J, Mahler F, Baumgartner I. Association of Cardiovascular Risk Factors with Pattern of Lower Limb Atherosclerosis in 2659 Patients Undergoing Angioplasty. Eur J Vasc Endovasc Surg 2006; 31: 59-63.
10. Erdheim J. Medionecrosis aortae idiopathica cystica. Virchows Arch Pathol Anat 1930; 276: 187.
11. Faries PL, Brener BJ, Connelly TL, Katzen BT, Briggs VL, Burks JA, Jr., Gravereaux EC, Carroccio A, Morrissey NJ, Teodorescu V, Won J, Sparacino S, Chae KS, Hollier LH, Marin ML. A multicenter experience with the Talent endovascular graft for the treatment of abdominal aortic aneurysms. J Vasc Surg 2002; 35: 1123-8.
12. Forrester JS, Libby P. The inflammation hypothesis and its potential relevance to statin therapy. Am J Cardiol 2007; 99: 732-8.
13. Griepp RB, Ergin MA, Lansman SL, Galla JD, Pogo G. The natural history of thoracic aortic aneurysms. Semin Thorac Cardiovasc Surg 1991; 3: 258-65.
14. Guo DC, Papke CL, He R, Milewicz DM. Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci 2006; 1085: 339-52.
15. Halloran BG, Davis VA, Mc-Manus BM, Lynch TG, Baxter BT. Localization of aortic disease is associated with intrinsic differences in aortic structure. J Surg Res 1995; 59: 17-22.
16. Hodgson KJ, Matsumura JS, Ascher E, Dake MD, Sacks D, Krol K, Bersin RM. Clinical competence statement on thoracic endovascular aortic repair (TEVAR) - multispecialty consensus recommendations. A report of the SVS/ SIR/SCAI/SVMB Writing Committee to develop a clinical competence standard for TEVAR. J Vasc Surg 2006; 43: 858-62.
17. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE, Powell JT. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001; 103: 2260-5.
18. Kaplan ML, Meier P. Nonparametric estimation from incomplete observations. J AM Stat Ass 1958: 457-81.
19. Katzen BT, Dake MD, MacLean AA, Wang DS. Endovascular repair of abdominal and thoracic aortic aneurysms. Circulation 2005; 112: 1663-75.
20. Kertai MD, Boersma E, Westerhout CM, van Domburg R, Klein J, Bax JJ, van Urk H, Poldermans D. Association between longterm statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 2004; 116: 96-103.
21. Leurs LJ, Visser P, Laheij RJ, Buth J, Harris PL, Blankensteijn JD. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular 2006; 14: 1-8.
22. Matsumura JS, Katzen BT, Hollier LH, Dake MD. Update on the bifurcated EXCLUDER endoprosthesis: phase I results. J Vasc Surg 2001; 33: S150-3.
23. Moore WS, Matsumura JS, Makaroun MS, Katzen BT, Deaton DH, Decker M, Walker G. Five-year interim comparison of the Guidant bifurcated endograft with open repair of abdominal aortic aneurysm. J Vasc Surg 2003; 38: 46-55.
24. Nagashima H, Aoka Y, Sakomura Y, Sakuta A, Aomi S, Ishizuka N, Hagiwara N, Kawana M, Kasanuki H. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg 2002; 6: 158-63.
25. Najibi S, Steinberg J, Katzen BT, Zemel G, Lin PH, Weiss VJ, Lumsden AB, Chaikof EL. Detection of isolated hook fractures 36 months after implantation of the Ancure endograft: a cautionary note. J Vasc Surg 2001; 34: 353-6.
26. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991; 5: 491-9.
27. Pleumeekers HJ, Hoes AW, van der Does E, van Urk H, Hofman A, de Jong PT, Grobbee DE. Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am J Epidemiol 1995; 142: 1291-9.
28. Rosenson RS. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy. Am J Cardiovasc Drugs 2001; 1: 411-20.
29. Schillinger M, Domanovits H, Ignatescu M, Exner M, Bayegan K, Sedivy R, Polterauer P, Laggner AN, Minar E, Kostner K. Lipoprotein (a) in patients with aortic aneurysmal disease. J Vasc Surg 2002; 36: 25-30.
30. Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, Mao D, Goeddel LA, Hawkins CJ, Thompson RW. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 2005; 241: 92-101.
31. Thompson R, Lee J, Curci JA. The pathobiology of abdominal aortic aneurysm. In: Gewertz BL, editor. Surgery of the aorta and its branches. Pihladelphia: WB Saunders; 2000.
32. United Kingdom Small Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346: 1445-52.
33. Vainas T, Lubbers T, Stassen FR, Herngreen SB, van Dieijen-Visser MP, Bruggeman CA, Kitslaar PJ, Schurink GW. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 2003; 107: 1103-5.
34. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23.
35. Wilson WR, Evans J, Bell PR, Thompson MM. HMG-CoA Reductase Inhibitors (Statins) Decrease MMP-3 and MMP-9 Concentrations in Abdominal Aortic Aneurysms. Eur J Vasc Endovasc Surg 2005; 3: 259-62.
36. Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals. Deviation of man from the usual pattern. Circ Res 1969; 25: 677-86.